Programme

NextGEN ENETS Scientific Workshop 2026

Thursday, 1 October 2026

18:00 – 18:30 | Delegate Arrival and Registration

18:30 – 19:00 | Welcome and Opening Remarks
Introduction: Nicola Fazio, ENETS Chair

19:00 – 19:30 | Keynote Lecture: The Journal of Neuroendocrinology (JNE)
Speaker: Wouter de Herder

19:30 – 20:00 | Special Session: Introduction to Scientific Communication
Speaker: Germán Orizaola Pereda

20:00 – 21:30 | Dinner

Friday, 2 October 2026

07:30 – 08:30 | Breakfast

08:30 – 10:30 | Scientific Presentations: Session I (Presentations 1–4)

08:30 – 09:00 | Scientific Presentation 1

  • 10-min presentation - Speaker: Lavinia Benini, oncology, Italy. Project title: “Optimal clinical management of well-differentiated NET G3”.
  • 20-min scientific feedback and discussion with senior faculty.

09:00 – 09:30 | Scientific Presentation 2

  • 10-min presentation - Speaker: Alice Castenetto, basic science, Italy. Project title: “Reprogramming Tumour Resistance: FAK as a Therapeutic Lever in NETs”.
  • 20-min scientific feedback and discussion with senior faculty.

09:30 – 10:00 | Scientific Presentation 3

  • 10-min presentation - Speaker: Manfredi d’Afflitto, gastroenterology, United Kingdom. Project title: “Spatial characterisation of the Tumour Microenvironment in Small-Intestinal NETs”.
  • 20-min scientific feedback and discussion with senior faculty

10:00 – 10:30 | Scientific Presentation 4

  • 10-min presentation - Speaker: Laura De Bona, oncology, Italy. Project title: “Mutational landscape of pancreatic NETs before and after temozolomide treatment: a retrospective monocentric study”.
  • 20-min scientific feedback and discussion with senior faculty.

10:30 – 11:00 | Coffee Break

11:00 – 13:00 | Scientific Presentations: Session II (Presentations 5–8)

11:00 – 11:30 | Scientific Presentation 5

  • 10-min presentation - Speaker: Luigi Guerrera, oncology, Italy. Project title: “Gastrointestinal NETs: insights from next-generation sequencing”.
  • 20-min scientific feedback and discussion with senior faculty.

11:30 – 12:00 | Scientific Presentation 6

  • 10-min presentation - Speaker: María Hernández Llorens, basic science, Spain. Project title: “PTPRN, a novel key regulator of tumour progression and hormone secretion in NETs”.
  • 20-min scientific feedback and discussion with senior faculty.

12:00 – 12:30 | Scientific Presentation 7

  • 10-min presentation - Speaker: Joe Ibrahim, basic science, Belgium. Project title: “Risk stratification in pancreatic NETs using multi-omics and deep learning”.
  • 20-min scientific feedback and discussion with senior faculty.

12:30 – 13:00 | Scientific Presentation 8

  • 10-min presentation - Speaker: Konstantinos Iliakopoulos, surgery, Greece. Project title: “Second Neoplasms in Sporadic NEN: A Multicentre European Analysis”.
  • 20-min scientific feedback and discussion with senior faculty.

13:00 – 14:00 | Lunch

14:00 – 14:30 | Special Session: Navigating the Grant Application Processs
Speaker: Justo Castaño

14:30 – 16:00 | Scientific Presentations: Session III (Presentations 9–11)

14:30 – 15:00 | Scientific Presentation 9

  • 10-min presentation - Speaker: Claire Mok, oncology, Australia. Project title: “PRRT efficacy in oligodiscordant gastroenteropancreatic NETs”.
  • 20-min scientific feedback and discussion with senior faculty.

15:00 – 15:30 | Scientific Presentation 10

  • 10-min presentation - Speaker: Sean Morgan, oncology, United Kingdom. Project title: “Impact of mid-treatment imaging during PRRT in advanced gastroenteropancreatic NETs”.
  • 20-min scientific feedback and discussion with senior faculty.

15:30 – 16:00 | Scientific Presentation 11

  • 10-min presentation - Speaker: Daniel Ruiz Palacios, basic science, Spain. Project title: “A study of the interaction between m6A modification and splicing in NETs”.
  • 20-min scientific feedback and discussion with senior faculty.

16:00 – 16:30 | Coffee Break

16:30 – 18:00 | Scientific Presentations: Session IV (Presentations 12–14)

16:30 – 17:00 | Scientific Presentation 12

  • 10-min presentation - Speaker: Mariacarmen Tricarico, oncology, Italy. Project title: “A-to-I RNA editing is a major source of neoantigens in pancreatic NETs”.
  • 20-min scientific feedback and discussion with senior faculty.

17:00 – 17:30 | Scientific Presentation 13

  • 10-min presentation - Speaker: Camilla Ullmann, pathology, Switzerland. Project title: “Targeting drug-tolerant cells – a strategy against acquired drug resistance in pancreatic NEN”.
  • 20-min scientific feedback and discussion with senior faculty.

17:30 – 18:00 | Scientific Presentation 14

  • 10-min presentation - Speaker: Brenna Van’t Veld, pathology, Netherlands. Project title: “PANDORA-Biomarker”.
  • 20-min scientific feedback and discussion with senior faculty.

Saturday, 3 October 2026

08:30 – 09:00 | Breakfast

19:30 – 20:00 | Science Communication Workshop: Translating Complex Research Messages
Speaker: Germán Orizaola Pereda

09:00 – 09:30 | Overview, Warm-up and Communication Tips

09:30 – 10:30 | Science Communication Presentation Block I: Condensed Communication (1–6)
Format: 3-minute intensive presentation followed by 7 minutes of structured feedback.

10:30 – 11:00 | Coffee Break

11:00 – 12:20 | Science Communication Presentation Block II: Condensed Communication (7–14)
Format: 3-minute intensive presentation followed by 7 minutes of rapid feedback.

12:20 – 12:45 | Closing Comments and Certificate Presentation
Nicola Fazio, ENETS Chair

12:45 – 13:45 | Lunch

Senior Faculty and their Conflicts of Interest Declarations (CoIs)

  • Nicola Fazio – European Institute of Oncology (IEO), Milan, Italy. He reports the following potential conflicts of interest:
    • Receipt of grants/research supports: Esteve, Merck.
    • Receipt of honoraria or consultation fees: Merck, MSD, Novartis, Pfizer, Boehringer, Ipsen, Recordati, ITM, Astellas, Astra Zeneca.
  • Justo Castaño – University of Córdoba, Córdoba, Spain. He reports the following potential conflicts of interest:
    • Receipt of grants/research supports: IPSEN.
    • Receipt of honoraria or consultation fees: Endocrine Oncology EiC (Bioscientifica), IPSEN, ADACAP (Novartis), Medscape (prIME Oncology).
    • Travel support: IPSEN, ADACAP (Novartis), Medscape (prIME Oncology).
  • Wouter de Herder – Erasmus MC, Rotterdam, Rotterdam, the Netherlands. He reports the following potential conflicts of interest:
    • Receipt of honoraria or consultation fees: Ipsen, Camurus and Novartis.
  • Rocío García-Carbonero – Hospital Universitario Doce de Octubre, Madrid, Spain. She reports the following potential conflicts of interest:
    • Receipt of grants/research supports: BMS.
    • Participation in a company sponsored speaker’s bureau: Astellas, Bayer, BMS, Boerhinger, Crinetics, Esteve, GSK, Hutchmed, Ipsen, ITM, MSD, Novartis, Novocure, PharmaMar, Pierre Fabre, Sanofi, Servier and Takeda.
  • Anna La Salvia – National Centre for Drug Research and Evaluation, Istituto Superiore di Sanità (ISS), Rome, Italy. She has no potential conflict of interest to report.
  • Hannes Leupe – University Hospital Leuven, Leuven, Belgium. He has no potential conflict of interest to report.
  • Gregory Kaltsas – National and Kapodistrian University of Athens, Athens, Greece. He reports the following potential conflicts of interest:
    • Receipt of grants/research supports: Ipsen, Recordati, Novo, Viokosmos.
    • Receipt of honoraria or consultation fees: Ipsen, Recordati.
  • Raj Srirajaskanthan – King’s College Hospital, London, United Kingdom. He reports the following potential conflicts of interest:
    • Receipt of grants/research supports: Novartis, Ipsen.
    • Receipt of honoraria or consultation fees: Novartis, Ipsen, Terumo, ITM, Advanz.
  • Germán Orizaola – Universidad de Oviedo, Oviedo, Spain. He has no potential conflict of interest to report.

Junior Faculty and their Conflicts of Interest Declarations (CoIs)

  • Lavinia Benini – European Institute of Oncology (IEO), Milan, Italy. She has no potential conflict of interest to report.
  • Alice Castenetto – University of Udine, Udine, Italy. She has no potential conflict of interest to report.
  • Manfredi d’Afflitto – University College London (UCL), London, United Kingdom. He reports the following potential conflicts of interest:
    • Other support (please specify): Novartis Pharmaceuticals UK Ltd: Accommodation expense coverage for UKINET Annual Conferences in 2024 and 2025. Registration fee RLT NET Masterclass 2025. Ipsen Developments Ltd: Event registration fee coverage for UKINET Annual Conference 2025.
  • Laura De Bona – Integrated University Hospital of Verona, Verona, Italy. She has no potential conflict of interest to report.
  • Luigi Pio Guerrera – Hospital of Varese, University of Insubria, Varese, Italy. He has no potential conflict of interest to report.
  • María Hernández Llorens – Research Institute Hospital 12 de Octubre, Madrid, Spain. She has no potential conflict of interest to report.
  • Joe Ibrahim – University of Antwerp, Antwerp, Belgium. He has no potential conflict of interest to report.
  • Konstantinos Iliakopoulos – Aretaieion University Hospital, National and Kapodistrian University of Athens, Athens, Greece. He has no potential conflict of interest to report.
  • Claire Mok – Royal North Shore Hospital, Sydney, Australia. She has no potential conflict of interest to report.
  • Sean Morgan – The Christie NHS Foundation Trust, Manchester, United Kingdom. He has no potential conflict of interest to report.
  • Mohamed Mortagy – Hampshire Hospitals NHS Foundation Trust, Basingstoke, United Kingdom. He has no potential conflict of interest to report.
  • Daniel Ruiz Palacios – Maimonides Biomedical Research Institute of Cordoba, Spain. He has no potential conflict of interest to report.
  • Mariacarmen Tricarico – University of Bari “Aldo Moro”, Bari, Italy. She has no potential conflict of interest to report.
  • Camilla Ullmann – Institute of Tissue Medicine and Pathology, University Bern, Switzerland. She has no potential conflict of interest to report.
  • Brenna Van‘t Veld – University Medical Center Utrecht, the Netherlands. She has no potential conflict of interest to report.

UEMS-EACCME® Accreditation Statement

The NextGEN ENETS Scientific Workshop 2026, Varese, Italy, Italy 01/10/2026 - 03/10/2026, has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 12.0 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at https://edhub.ama-assn.org/pages/applications.

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.